ReachMD
Be part of the knowledge.™Public Profile
- Professor of Medicine
- College of Medicine, Mayo Clinic,
- Rochester, MN
Disclosures Consultant/Independent contractor: Kesios Therapeutics; NOXXON Pharma; Skyline Therapeutics Limited; Consultant/Independent contractor (all to Mayo Clinic - Rochester): Amgen, Inc.; Bristol-Myers Squibb Company; Celgene Corporation; Janssen Pharmaceuticals, Inc.; Takeda Pharmaceutical Company Limited; Grant/Research support (all to Mayo Clinic - Rochester): AbbVie; Celgene Corporation; Janssen Pharmaceuticals, Inc.; Novartis Pharmaceuticals Corporation; Sanofi; Takeda Pharmaceutical Company Limited.
Affiliations Professor of Medicine Mayo Clinic College of Medicine Consultant, Division of Hematology Mayo Clinic Rochester, Minnesota
Dr. Shaji Kumar is a Consultant in the Division of Hematology at Mayo Clinic, and Professor of Medicine at the Mayo Clinic College of Medicine. A significant component of Dr. Kumar’s research efforts are directed toward studying novel treatment approaches in myeloma through well-designed clinical trials. He is Principal Investigator for multiple phase 1, 2, and 3 trials for plasma cell malignancies. From a translational research standpoint, his laboratory has focused on the development of new agents for plasma cell malignancies, with a particular focus on the tumor microenvironment. Dr. Kumar receives ongoing support for research from the National Institutes of Health and the National Cancer Institute. He is a member of several professional societies, including the American Society of Hematology, American Society of Clinical Oncology, American Association for Clinical Research, American Society for Blood and Marrow Transplantation, American Medical Association, Association of Physicians of India, and European Hematology Association. His work has appeared in peer-reviewed journals such as Lancet Oncology, Journal of Clinical Oncology, Blood Cancer Journal, Leukemia, American Journal of Hematology, Mayo Clinic Proceedings, Blood, and European Journal of Hematology. He also has editorial responsibilities with American Journal of Hematology, Lancet Haematology, and Leukemia. Dr. Kumar earned an MD from All India Institute of Medical Sciences, New Delhi, India, where he completed an internship, followed by a clinical residency in internal medicine and a senior residency in medical oncology. Dr. Kumar subsequently completed a residency in internal medicine and a fellowship in hematology/oncology at Mayo Graduate School of Medicine, Rochester, Minnesota. He then served as a research associate and Mayo Foundation Scholar in multiple myeloma at Dana-Farber Cancer Institute-Harvard Cancer Center.